314140 — RP Bio lnc Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual income statement for RP Bio lnc, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	97,923	114,964	138,109	151,046	123,967
Cost of Revenue
Gross Profit	12,639	12,938	17,779	15,569	7,198
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	92,944	110,058	130,785	144,424	124,660
Operating Profit	4,978	4,906	7,324	6,623	-694
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,209	4,291	5,669	5,658	-1,217
Provision for Income Taxes
Net Income After Taxes	4,616	3,813	4,316	5,437	-907
Net Income Before Extraordinary Items
Net Income	4,616	3,813	4,316	5,437	-907
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	4,616	3,813	4,469	5,437	-907
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	523	598	841	647	-103
Dividends per Share